Parkinson Disease

In interviews with patients with Parkinson disease and their care partners, study authors noted that OFF periods can impair socialization, physical function, leisure activities, driving, and other means of independence.

Neuropalliative care is an emerging field for those with conditions such as Parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome, and other diseases, but access to care remains limited, according to a recent survey.

Results of the SAFINONMOTOR open-label study found that safinamide was safe and effective in improving pain of patients with Parkinson disease at 6 months.

Patients with idiopathic Parkinson disease given Origanum majorana tea in combination with conventional medication exhibited significant improvements in depressive and nonmotor symptom burden vs placebo, although improvement of motor symptoms was not significant.

An overview of the latest news in Parkinson disease reported across clinical research.

Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.

An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.

Pimavanserin (Nuplazid) initiation among patients with Parkinson disease was associated with greater risk of 30-day hospitalization and mortality up to one year compared with non-users.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Findings of the Adult Changes in Thought study present a significant link between long-term air pollution exposure and increased risk of dementia.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

A significant risk of neurodegenerative disease was found in an analysis of male former professional soccer players, with defensive outfield players and those with careers longer than 15 years particularly at risk.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

People with prior incidence of traumatic brain injury and exposure to lead were shown to be at elevated risk of Parkinson disease development, with family history also found to influence risk.

Patients with Parkinson disease treated with acupuncture-related therapies combined with conventional medication exhibited significant improvements in motor function and experiences of daily living, although the quality of findings may warrant future research.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Patients with Parkinson disease who participated in weekly dance training with music exhibited no decline in motor function and motor or nonmotor experiences of daily living across a 3-year span.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Low-dose niacin uptake over 12 months was associated with improvements in the UPDRS III motor score, as well as fatigue and mood in people with Parkinson disease.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.

Occupational exposure to the herbicide paraquat was not found to be associated with a greater risk of Parkinson disease or increased risk of mortality related to other causes.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Findings from a retrospective cohort study revealed that individuals with osteoarthritis are more susceptible to the development of Parkinson disease.

An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.

Deep brain stimulation of the subthalamic nucleus was shown to remain effective in treating motor complications of people with Parkinson disease 15 years after initial surgery.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

People who live in areas that have higher exposure to nitrogen dioxide were found to be at greater risk of Parkinson disease.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.